🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Softgel(s) Serving Size
40 Servings
Fat/Fatty Acid Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Calories
30 {Calories}
Total Fat
2.5 Gram(s) (4% DV)
Omega-6 Fatty Acids
Omega-9 Fatty Acids
Phospholipid Complex
Plant Sterol Complex
33 mg

Other Ingredients

organic Flaxseed Oil Softgel Soy Phospholipid concentrate organic Styrian Pumpkin seed oil organic Flaxseed particulates Plant Sterols Antioxidant Blend

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult Male (18-50 Years) Gluten Free

Product Information

📋 Directions for Use

Suggested Use: 3-9 softgels per day, with or without a meal.

⚠️ Warnings & Precautions

Store in a cool, dry place, out of reach of children.

🧪 Formulation Notes

~ Non-GMO, Gluten Free

Men's Health & Vitality Formula

Additional Information

FRESHNESS DATING

Keep bottle tightly closed. Store in a cool, dry place, out of reach of children.

FROM OUR FAMILY TO YOURS Barbara Barlean David Barlean Bruce Barlean

Pathway To A Better Life

44000-05 Product of U.S.A.

Product Details

UPC / SKU 7 05875 10019 9
DSLD Entry Date 2016-03-24
Product Type Fat/Fatty Acid
Form Softgel Capsule
Brand Barlean's
DSLD ID 57295
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →